• Exciting News: Interview with Our CTO on Revolutionary Blood Clot Treatment
We are thrilled to announce that our Chief Technology Officer, Keitaro Yoshimoto, was recently featured in an interview with Drug Discovery News, discussing groundbreaking advancements in synthetic DNA for safer blood clot treatments. The full article can be read here.

• Breakthrough Anticoagulant Treatment Showcases Power of MACE® Technology (LinkBIO.Co.LTD Patent)
The recent news release by the University of Tokyo unveils a groundbreaking DNA-based anticoagulant therapy. (August 22, 2023)

• Our researcher, Osman Waleed, and Tokyo University’s CTO, Associate Professor Keitaro Yoshimoto, have announced their research achievement entitled “Steric hindrance and structural flexibility shape the functional properties of a guanine-rich oligonucleotide” published in Nucleic Acids Research with an impact factor of 19. (August 1, 2023)

• We have published our new research paper to prove the efficiency of our MACE SELEX Technology for the selection of highly specific DNA Aptamer for small molecules target. (Dec 02, 2022)

• LinkBIO and Nara Medical University have signed a “Joint Research and Development Agreement for the Treatment of Blood Diseases”. (July 25, 2022)

• Joint research collaboration between LinkBIO and HitGen to improve drug discovery screening platform for small molecules. (June 01, 2022)

• We are pleased to announce that Nikkei Biotechnology has published the latest article on MACE® Tech for Aptamer Screening which includes commentary from our CTO Professor Keitaro Yoshimoto. (May 13, 2022)

• Funakoshi has published a new article about LinkBIO MACE® Technology for Aptamers Separation and how it could accelerate both Therapeutics and Diagnostics Discovery P5~7). (March 1, 2022)

• We are happy to announce that we successfully got our MACE® Trademark Registration (Trademark Registration No. 6515690)- (February 18, 2022)

• We are pleased to announce the Grant of Japan Patent No. 6994198 for “Methods for screening nucleic acid aptamers”. (December 15, 2021)

• Strategic Alliance Agreement with Funakoshi (December 1, 2021)

• Announcement of collaborative research contract with Maruho Co., Ltd. (October 13, 2021)

• Academic paper related MACE® was accepted (Sep. 22, 2021)

• Patent registration in China (Sep. 21, 2021)

• Appointment of new advisor (Sep. 01, 2021)

• Receipt of subsidies (July. 15, 2021)

• Patent registration in Taiwan (Jun 21, 2021)• Patent registration in USA (Apr. 13, 2021)

• Appointment of new director (Mar. 06, 2021)